Abstract: Analysis of the Postoperative Absorption Process of Unsintered Hydroxyapatite Particles/Poly L-Lactide Composite Device (OSTEOTRANS MX®) for Facial Bone Fractures in 13 Cases

Sayo, Tatsuta; Hayashi, Minoru; Tokunaka, Ryohei; Muramatsu, Hideyuki; Kadomatsu, Koichi

doi:10.1097/01.gox.0000546724.61635.67

Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.

Plastic and Reconstructive Surgery - Global Open

2018

DOI: 10.1097/01.gox.0000546724.61635.67

|View full text |Cite

Abstract: Analysis of the Postoperative Absorption Process of Unsintered Hydroxyapatite Particles/Poly L-Lactide Composite Device (OSTEOTRANS MX®) for Facial Bone Fractures in 13 Cases

Tatsuta Sayo

Minoru Hayashi

Ryohei Tokunaka

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Biodegradable implants for orbital wall fracture reconstruction

Jang

Kim

2020

Arch Craniofac Surg

View full text Add to dashboard Cite

Background: Due to the different handling properties of unsintered hydroxyapatite particles/poly-L-lactic acid (uHA/PLLA) and polycaprolactone (PCL), we compared the surgical outcomes and the postoperative implantation accuracy between uHA/PLLA and PCL meshes in orbital fracture repair. Methods: Patients undergoing orbital wall reconstruction with PCL and uHA/PLLA mesh, between 2017 and 2019, were investigated retrospectively. The anatomical accuracy of the implant in bony defect replacement and the functional outcomes such as diplopia, ocular motility, and enophthalmos were evaluated. Results: No restriction of eye movement was reported in any patient (n = 30 for each group), 6 months postoperatively. In the PCL group, no patient showed diplopia or enophthalmos, while the uHA/PLLA group showed two patients with diplopia and one with enophthalmos. Excellent anatomical accuracy of implants was observed in 27 and 22 patients of the PCL and uHA/PLLA groups, respectively. However, this study showed that there were neither any significant differences in the surgical outcomes like diplopia and enophthalmos nor any complications with the two well-known implants. Conclusion: PCL implants and uHA/PLLA implants are safe and have similar levels of complications and surgical outcomes in orbital wall reconstruction.

show abstract

Biodegradable implants for orbital wall fracture reconstruction

Jang

Kim

2020

Arch Craniofac Surg

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Abstract: Analysis of the Postoperative Absorption Process of Unsintered Hydroxyapatite Particles/Poly L-Lactide Composite Device (OSTEOTRANS MX®) for Facial Bone Fractures in 13 Cases

Cited by 1 publication

References 0 publications

Biodegradable implants for orbital wall fracture reconstruction

Biodegradable implants for orbital wall fracture reconstruction

Contact Info

Product

Resources

About